Experienced in Erythema Multiforme

Francois Tremblay

Montreal, QC, CA 
Experienced in Erythema Multiforme
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Francois Tremblay practices in Montreal, Canada. Mr. Tremblay is rated as an Experienced expert by MediFind in the treatment of Erythema Multiforme. His top areas of expertise are Cystic Fibrosis, Scalded Skin Syndrome, Erythema Multiforme, and Stevens-Johnson Syndrome.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Erythema Multiforme.

Gender
Male

Locations

Montreal, QC, Canada
Other Locations
Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
Enrollment Status: Completed
Publish Date: November 22, 2022
Intervention Type: Drug
Study Drug: ELX-02 Ribosomal-Selective Glycoside
Study Phase: Phase 2
View 2 Less Clinical Trials

20 Total Publications

20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights.
20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: September 30, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tremblay's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile